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PITTs vs. BARR-TONKO BILLS: AN IN-DEPTH
COMPARISON OF PROPOSED ANTI-DOPING
LEGISLATION IN HORSE RACING
PeterJ. Sacopulos, Esq.*
I. INTRODUCTION

Changing an established procedure or method often
results in strong positions. Horse racing is no exception. Although
many in the industry feel that the current methods and laws for
medicating race horses are in need of improvement, as Figure 1
demonstrates, exactly how this matter is dealt with has
organizations, owners, trainers, jockeys, and animal advocates
arguing about the best way to do just that.' Whether you like it or
not, the horse has left the barn on this issue. Just over a year
ago, the most recent versions of two-horse, anti-doping bills were
introduced before Congress: The Horseracing Integrity and Safety
Act of 2015 ("HR 2641") filed on June 3, 2015 by Rep. Joe Pitts
(R-PA),2 and The Thoroughbred Horseracing Integrity Act of 2015
("HR 3084"), filed on July 16 by Rep. Andy Barr (R-KY).3
Although similar in many ways, each has a different scope
regarding the types of racing to be regulated.
HR 2641, hereinafter referred to as the Pitts Bill, proposes
a ban on providing medications within twenty-four hours of a
race, and a "three strikes and you're out" penalty for

Peter J. Sacopulos, Esq. received his Doctor of Jurisprudence from Indiana
University School of Law in Indianapolis in 1988 and a B.A. in International Relations
from Tulane University in 1984.
1 Ray Paulick, Barr-Tonko Bill Delivers What Thoroughbred Industry Wants,
Needs,
PAULICK
REPORT
(Aug.
11,
2015,
1:51
PM),
http://www.paulickreport.com/news/ray-s-paddock/barr-tonko-bill-delivers-what-

thoroughbred-industry-wants-needs/ (according to a Paulick Report online user poll, the
majority of those in the thoroughbred racing community favor an independent, nongovernmental agency for overseeing medication regulations) [http://perma.cc/J3TW-S9RF].
2 Horseracing Integrity and Safety Act of 2015, H.R. 2641, 114th Cong. (2015).
3 Thoroughbred Horseracing Integrity Act of 2015, H.R. 3084, 114th Cong.
(2015).
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Thoroughbred, Quarter Horse, and Standardbred racing. 4 HR
3084, hereinafter referred to as the Barr-Tonko Bill, proposes the
creation of a federal, non-governmental racing organization,
overseen by the United States Anti-Doping Agency ("USADA")
and, as its name suggests, would apply solely to Thoroughbred
racing.5 Barr-Tonko's provisions are based, in part, on the
USADA Protocol and its attached World Anti-Doping Code
Articles, employing existing industry "best-practices" to create a
uniform, anti-doping program similar to the one successfully used
in human sports. 6
Both bills have been modeled after prior similar bills and
existing regulatory regulations that govern anti-doping in human
sports.7 The impetus for proposed legislation is a desire to utilize
federal law to empower a private, not-for-profit, anti-doping
entity that would create a body of uniform rules to promote
interstate business, competition fairness, and customer
confidence in the sport of horseracing - the same as exists in
human sports.8 Although the two bills have their share of
supporters and detractors, there is a general tone in the industry
that some kind of oversight is needed when it comes to
medication regulations in horse racing.9
Figure 1 below shows the results of an online reader poll,
indicating that 70 percent of 1,678 readers who participated in
the poll are in favor of an independent, non-governmental agency
to oversee Thoroughbred racing.1 0
Do you support federal legislation to create an Independent, non-governmental agency to oversee
medication regulations for Thoroughbred racing in all U.S. states?
Yes 70.5% - (1183 voteu)

No 29.X% -(495 voteS)
Back to vote
Archive

H.R. 2641 § 4(b)(1)-(3).
5 H.R. 3084 § 5(a).
6 See id. § 2(5)-(6).
Compare H.R. 3084 § 2(5)-(7), with H.R. 2641 § 4(g).
8
H.R. 3084.
9 See Paulick, supra note 1.
10 Id.
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Figure 1 According to a Paulick Report online user poll, the majority of those
in the Thoroughbred racing community favor an independent, nonSource:
governmental agency for overseeing medication regulations.
http://www.paulickreport.com/news/
ray- s-paddocklbarr-tonko-bill-delivers-what-thoroughbred-industry-wantsneeds/.

II. COMPARISON OF THE PROPOSED LEGISLATION
These dual horseracing anti-doping bills, while broadly
similar, differ in scope. A comparison and analysis of the specific
provisions/elements of each proposed bill follows. For convenience
and ease of distribution, an abbreviated version of this
comparison has been provided in Table 1 below.
A. Veterinary Ethics
The Pitts Bill mandates that all drug treatments adhere to
the Principles of Veterinary Medical Ethics of the American
Veterinary Medical Association ("Principles") that are in effect on
the date the bill becomes law." The Pitts Bill would effectively
codify the 2015 versions of those Principles permanently, as
federal law, thereby requiring periodic acts of Congress to keep
up with changes made by the American Veterinary Medical
Association. 12
Conversely, the Barr-Tonko Bill dictates that the
Principles are to be "considered." 13 As proposed, the Barr-Tonko
Bill does not require adherence to the standards of veterinary
ethics, unless required by a governing organization called the
Thoroughbred Horseracing Anti-Doping Authority ("THADA"),
4
which would be created as part of the Barr-Tonko Bill.1 This
organization is explained and analyzed further below.

I H.R. 2641, 114th Cong.
12 See id.
3 H.R. 3084 § 7(a).
1 Id.

§ 3(2).
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B. RacedayMedication
The Pitts Bill bans the administration of all medication
within at least a twenty-four hour window. 15 Although some
might call this a "ban on race day medications," the Pitts Bill
explicitly does allow for the use of medication that can affect the
outcome of a race so long as it is given more than twenty-four
hours before a race, and the application meets the USADA's
guidelines.16 Many would argue that a true "ban on race day
medications" would absolutely ban the presence of performance
enhancing drugs in a horse during a race rather than merely
prohibiting administration of any drugs within twenty-four hours
of that race, principally because some drugs, such as
Phenylbutazone, have performance enhancing effects that last for
longer than twenty-four hours.17
The Barr-Tonko Bill leaves open the question of whether
or not to ban the administration of medications on race day or to
go further and ban medications that may have an effect on a
horse on race day.18 Addressing the issue about race-day
medication is left to the discretion of the THADA. 19
C. Characterof the New Anti-Doping Authority
The Pitts Bill designates the USADA as the independent,
anti-doping organization to regulate interstate horseracing at the
federal level. 20 Conversely, the Barr-Tonko Bill supplies much
more detail about the authority to be created. 2 1 Specifically, if
enacted, Barr-Tonko would create the aforementioned, non-profit
corporation, the THADA. 22 Pursuant to the proposed Barr-Tonko
Bill, the THADA would initially be composed of the following:

H.R. 2641 § 4(b)(1)(C).
11 Id. § 4(b)(1)(A)-(C).
17 See Sid Gustafson, Drugs and Racehorses, N.Y. TIMES: THE RAIL (Jun. 4, 2008,
3:42
PM),
http://therail.blogs.nytimes.com/2008/06/04/drugs-and-racehorses/
[http://perma.cc/4PRM-MN441.
8 H.R. 3084 § 2(4).
15

19 Id.
20
21
22

H.R. 2641
H.R. 3084
Id. § 5(a).

§ 2(1).
§ 2(4).
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(a) the Chief Executive Officer of USADA;
(b) five USADA board members; and
(c) five representatives of the industry itself.2 3

These five industry representatives would be selected from
owners, breeders, trainers, veterinarians, racing associations,
state racing commissions, and jockeys. 24 Should the USADA later
withdraw from direct participation, the newly formed the THADA
would continue under the governance of the five industry
representatives and by its governing bylaws. 25
The Barr-Tonko Bill further provides that no THADA Board
Member would be allowed to have a financial conflict of interest. 26
Specifically defined areas of conflict of interest include the
following:
(a) provider of goods or services to covered horses;
(b) as an officer or official in the Thoroughbred
industry; or
(c) as an employee of any of the above. 27
The THADA Board Members would serve staggered,
three-year terms to assure that the entire board will not be
replaced at once. 28 The THADA Board Members would be limited
to two consecutive terms. 29 The Barr-Tonko Bill seems to provide
for neutral oversight.3 0 How the USADA guards against conflicts
of interest is not addressed. 3 1

23 Id.
24 Id.

- Id.
2 Id.
27 Id.
- Id.

§ 5(b).
§ 5(b)(1)-(2).
§ 5(b)(4).
§ 5(c).
§ 5(d).

29 Id.

:) Id. § 5(e).
m See id. § 5.
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D. Duties of the Anti-DopingAuthority
The Pitts Bill supplies less detail than the Barr-Tonko Bill
regarding the duties of the anti-doping authority. As proposed
under the Pitts Bill, the USADA is expressly tasked to:
(a) develop and publish lists of banned and allowed substances,
methods, and treatments;
(b) create programs for education, research, testing, and
adjudication; and
(c) exclude from participation any violators of either federal or
state anti-doping rules.32

In contrast, the Barr-Tonko Bill provides more specific
detail regarding the duties of the anti-doping authority,
identifying the duties of the new authority to include:
(a) the development and publication of official lists
of banned and allowed substances, methods, and
treatments;
(b) the development and publication of documents
detailing testing procedures, standards, and
protocols, as well as laboratory procedures and
standards of accreditation;
(c) the development and publication of documents
detailing the investigational,
charging, and
adjudication procedures;
(d) the development of programs for education,
research, and testing; and
(e) the exclusion of violators of federal or state antidoping rules from participation in thoroughbred
racing. 33
E. Powers of Newly CreatedAnti-DopingAuthority
The Pitts Bill supplies no detail regarding the express
powers of the USADA anti-doping authority that is to be

32

33

H.R. 2641, 114th Cong. § 4(b)(1)(A)-(C) (2015).
H.R. 3084, 114th Cong. § 6(a) (2015).
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created.34 Presumably, such powers will be set forth in the rules
that would be promulgated by the USADA, if the Pitts Bill
becomes law.35 The Barr-Tonko Bill enumerates and sets forth

the basic powers of the THADA, its contemplated anti-doping
authority.3 6 Specifically, these powers include:
(a) access to the offices, track facilities, and
businesses of all licensees;
(b) the powers of search and seizure;
(c) the ability to issue and enforce subpoenas (to
compel persons to be questioned concerning alleged
violations under oath), and subpoenas duces tecum
(compelling the production of documents relevant
to such an investigation by the authority); as well
as
(d) "other" investigatory powers. The scope and
practice of these THADA powers are expected to be
detailed in the rules to be promulgated if the Act is
brought into force as law.37

F. Doping Penalties
The Pitts Bill, while providing fewer specifics, does reveal
three features regarding the imposition of doping violation
penalties2 8 Those factors are:
(a) a "one and done" temporal exclusion penalty for
the presence of any listed banned substance in a
tested animal;
(b) a "three strikes and you're out" temporal
exclusion penalty for violations involving allowed
substances that are found to have been
administered in violation of the allowed pre-race
window, and;

MSee H.R. 2641.
:m See id.
3 H.R. 3084 § 4(c).
37

Id.

:' H.R. 2641

§ 4(b)(3)(A)-(C).
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(c) reciprocal federal suspensions matching any
temporal exclusion penalties imposed by State
Racing Commissions pursuant to state law. 39
Notably, the Pitts Bill does not provide for any
financial penalties for violators, nor does it require
the return of purse monies in the event that a
horse wins money while in violation of the rules. 40
The anti-doping penalties and corresponding rule under
the
Barr-Tonko
proposed
legislation
would
impose
punishment/penalties for the following:
(a) the presence of prohibited substances in a
sample even accidentally or without knowledge
thereof (i.e., strict liability);
(b) the attempted use of a prohibited substance;
(c) the possession of prohibited substance or
method;
(d) any attempted possession of prohibited
substance or method;
(e) the administration of prohibited substance or
method;
(f a refusal or failure to submit horse for testing
without compelling justification;
(g) the tampering with any doping control;
(h) any attempted tampering with any doping
control;
(i) the trafficking of any prohibited substance or
method;
(j) any attempted trafficking of any prohibited
substance or method, and;
(k) complicity with any anti-doping violation (i.e.,
conspiracy).41
The specific categories and levels of penalty and
punishment would likely be based on a system that would

39 Id.

40 See id.
41

H.R. 3084 § 7(c).
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consider both mitigating and aggravating circumstances, as well
as the licensee's record and the facts and circumstances
42
The
surrounding each violation or combination of violations.
THADA would be tasked with creating a uniform set of rules
imposing sanctions against covered persons for anti-doping rule
violations, and these must include the imposition of sanctions, up
to and including lifetime bans from horseracing. 43
G. Adjudication & DisciplinaryProcedure
44
The Pitts Bill fails to detail any disciplinary procedures.
Instead, it contemplates that such details will be established by
way of rules to be promulgated by the USADA, subsequent to the
Act being enacted. 45 Although not specifically stated, it is
probable that the Pitts Bill, if successful, will adopt procedures of
adjudicating and discipline from the Administrative Order and
Procedures Act ("AOPA").4 6 This would make good sense and
likely result in a smoother transition in those areas, as many
state commissions have adopted, in large part, the AOPA for
adjudicating disciplinary proceedings.
Conversely, the Barr-Tonko Bill bases its rules, in this
regard, largely on those employed by the USADA and
international "best practices." 47 The Barr-Tonko Bill also sets
48
forth the main components of disciplinary actions. However, the
specific mechanics of the adjudication and disciplinary procedures
49
The listed
are left to be established by the future rules.
the
do
address
Bill
Barr-Tonko
the
under
categories
disciplinary
due process of law issue by mandating:

(a) requirements for notification of rule violations;
(b) hearing procedures;
(c) burdens of proof and which party possesses them;

12

See id.

§

7(0.

43 Id.

See H.R. 2641 § 4(c).
Id.
4 See 5 U.S.C. § 551 (2016); see H.R. 2641.
4 H.R. 3084, 114th Cong. § 7(0) (2015).
Id. § 7(c)-(0.
44
45

49

See id.
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(d) presumptions;
(e) evidentiary rules;
(f) appeals process;
(g) confidentiality and public reporting guidelines; and
(h) due process of law requirements.50
H. Preemption of State Law and Reciprocity Regarding State Law
Violations
These competing bills present diametrically opposed
positions regarding the issue of preemption of state law. The Pitts
Bill expressly provides that state laws would not be preempted by
its enactment.5 1 In direct contrast, the Barr-Tonko Bill provides
for a new regime regarding anti-doping rules and regulations
that would preempt state law on the same or similar subject
matter. 52 Arguably, the Barr-Tonko Bill would provide greater
uniformity for those participants owning, training, and running
horses in multiple states.
The Pitts Bill is clear and expressly provides that the new
federal law created in connection with, and pursuant to its
authority, will recognize state law violations. 53 Further, the Pitts
Bill contemplates that the association of new federal law(s) would
enforce the participation ban instituted by state authorities via
reciprocity. 54 In contrast, the Barr-Tonko Bill "occupies the field"
as the sole, nationwide anti-doping authority, so there is no need
to contemplate the issue of reciprocity regarding state law
violations.5 5
L Delegation ofAuthority to State Commissions
The Pitts Bill does not expressly address the issue of
delegation of authority.5 6 Should the Pitts Bill become law, it is
probable that such delegated powers will be supplied by way of

5

Id. § 7(e).
See H.R. 2641, 114th Cong.
H.R. 3084 § 8.
H.R. 2641 § 4(d)(1)(B).

54

Id.

55
56

H.R. 3084 § 9(1).
See H.R. 2641.

50
51
52

§4

(2015).
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future rules. In contrast, the Barr-Tonko Bill expressly states
that the Authority, THADA, may enter into agreements (i.e.,
contracts) with State Racing Commissions to implement the
strictures of the Act within that specific state.57 Pursuant to the
Barr-Tonko Bill, such agreements would remain terminable at
the discretion of the newly established federal authority.5 8
J. Funding
Funding is a key factor with any proposed legislation.
Costs of staffing, implementation, enforcement, and testing are
all significant, and both proposed bills address the issue.5 9 Under
the Pitts Bill, funding for the new federal program would derive
from individual agreements between the USADA and racetracks
that offer interstate wagering. 60 Whether or not there would be
individually negotiated agreements bearing some commonality is
not defined. 61 The Pitts Bill also does not explain how costs
should be allocated among the various tracks or how the USADA
should arrive at its annual horseracing anti-doping budgets. 62
The Barr-Tonko Bill provides that the initial funding of
the Authority is to be supplied by loans and/or donations secured
by the THADA. 63 Once it is up and running, the bill requires the
THADA to create a budget each year, with the first year's budget
being subject to a supermajority vote of the Board (this would
result in some of the Board Members from the horse racing
industry being required to approve the budget).64 In the event
that any subsequent year's budget exceeds the previous year's
budget by more than five percent, that budget must be passed by
a supermajority of the THADA Board as well.6 5

On or before November 1st of this year (2016), and each
subsequent year, the THADA would be required to produce

57 H.R. 3084 § 9(1).
Id.
59 H.R. 2641
-0 H.R. 2641
61 Id.
58

62

§ 5(b)(2);
§ 5(b)(2).

Id.

- H.R. 3084 § 12.
6 Id. § 12(2).
(z Id.

H.R. 3084

§ 12.
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documents setting forth its estimated costs (for annual programs,
plus the full payoff of any outstanding loans) on a per starter
basis, in line with its approved annual budget.6 6 This information
would be supplied to each State Racing Commission, which would
then calculate and pay its proportional share of the budget.67 It is
clear that funding, and lots of it, will be needed for operational
and enforcement procedures under either bill. What is equally
clear and certain is that the necessary subject of funds and
funding will be a topic of intense debate with regard to both bills.
K. FederalReview
The bills differ as to proposed and contemplated federal
review. The Pitts Bill, as proposed, calls for no federal review for
spending or efficacy. 68 Conversely, the Barr-Tonko Bill requires
review of the newly created THADA. 69 Specifically, the BarrTonko Bill would require, in the third year of operation and every
fourth year thereafter, that the Comptroller General supply
Congress with a report evaluating the THADA's spending and
efficacy. 70 Federal
and/or
Congressional
review
of the
authorities's spending and operations will be required, whether
that authority be established by the Pitts Bill or Barr-Tonko Bill.
It is likely that the Government Accountability Office ("GAO"),
the federal agency that provides auditing, evaluation and
investigative services for the United States Congress, would
perform review and reporting.7 1
L. Public Notice & Comment Periodfor Rules to Be Promulgated

public

Interestingly, the Pitts Bill directly addresses the issue of
notice and comment, but only with regard to the

- Id. § 12(3).
67 Id.
- H.R. 2641, 114th Cong. § 5(b)(2) (2015).
6' See H.R. 3084, 114th Cong. (2015).
70 Id. § 5(0).
71

About

GAO,

U.S.

GoVT

ACCOUNTABILITY

OFF.,

http://www.gao.gov/about/index.html (last visited Oct. 10, 2016) [http://perma.cc/LL3NKSG2].
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drugs lists. 7 2 In contrast, the Barr-Tonko
comment on all aspects of its anti-doping
but not limited to, drug lists (subject to
types of rule violations, hearings, and

sanctions."

However, all federal rules are required to be promulgated
with a prior, public notice and comment period so that
stakeholders and interested parties may set forth their
objections, criticisms, comments, and concerns to be considered
by the federal rule makers, prior to enactment of new federal
regulations. 74 Given the issue of race day administration of Lasix
and the multitude of issues contained in both proposed bills, the
time allotted for comments will need to be substantial, as many
stakeholders and interested parties with varied positions and
agendas will, no doubt, have plenty of comments. Regarding the
issue of consultation and notice relative to the development of
new federal rules, both acts are subject to a federal notice and
comment period.7 5 Additionally, both proposed bills contemplate
rules developed with consultation from interested parties and
stakeholders, including State Racing Commissions, race-hosting
associations, and horsemen's groups. 7 6
M. Rule Prom ulgation Deadline
Interestingly, the Pitts Bill states that new rules are to be
published within one year of enactment of the law.77 The Barr-

Tonko supplies more detail, stating that the lists of permitted
and prohibited substances and methods shall be published by
January

1, 2017.78

The Barr-Tonko Bill also provides that

modification of this initial list must be effective within 120 days
of the enactment of the Act, and that the lists of prohibited and
allowed substances and methods are subject to periodic review

H.R. 2641 § 4(e)(1).
73 H.R. 3084 § 7(e).
7 5 U.S.C. 551, §§ 551-559 (2016).
72

75

Id.

3084 § 7(e). See H.R. 2641 § 4(e)(1).
77 H.R. 2641 § 4(c).
78 H.R. 3084 § 7(b)(2).
MH.R.
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and modification, after an appropriate public/industry notice and
comment period.7 9
N. Testing to Be PerformedBy
Significantly, the Pitts Bill does not address the issue of
testing, or who should perform it, at all.8 0 Based on current law,
federal regulation will, at a minimum, require accredited
laboratories that demonstrate they can perform standard, defined
procedures for such tasks as collection, storage and transfer, and
testing of serum and urine samples. 8 ' Presumably, this subject
will be addressed, clarified, and specified as the Pitts Bill makes
its way through the legislative process. In contrast, the BarrTonko Bill expressly states that such testing is to be performed
by independent, THADA-accredited laboratories, pursuant to the
procedural rules to be promulgated once the Act is passed. 82
While Barr-Tonko more specifically addresses the issues of how,
by whom, and when testing will be performed, it does leave open
areas for future discussion and specification. 8 3
0. Reduction in Penalty for Cooperationand Informing
The Pitts Bill states that the new federal Anti-Doping
Authority may suspend a violator's period of exclusion if the
violator cooperates and supplies "substantial assistance"
regarding other violations of the Act's anti-doping rules or any
state or federal law. 8 4 However, it does not outline or include any
details or specifics regarding how this "flip" provision will
function or be limited.8 5 Presumably, the first to provide this
"substantial assistance" will receive the most benefit. Consistency
under such an approach is usually problematic, but may be
unavoidable for overall enforcement.

7 Id.
8

See H.R. 2641

§ 4(b).

81 See H.R. 2641.

H.R. 3084 § 7(d).
3 See id.
84 H.R. 2641 § 4(d)(1).
8 See id.
82
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The Barr-Tonko Bill supplies more detail, setting forth
that the new federal law will follow the sanction elimination and
reduction policies found in the USADA Anti-Doping Protocol.8 6
Based on the USADA Anti-Doping Protocol, one would expect
that the following leniency factors would apply to federal
Thoroughbred racing violations:
(a) lack of fault, as where prohibited substance was
introduced
accidentally,
through
sabotage,
contamination, mislabeling, etc.;
(b) a violator's rendering of substantial assistance
in identifying other violations;
(c) immediate acknowledgment of violation when
confronted; and
(d) disclosure of violation prior to collection of
evidence thereof.8 7

The Barr-Tonko Bill framework does provide more
substantive guidance than the competing Pitts Bill in this regard.
However, the key to integrity and enforcement is, and will be, in
consistency, uniformity, and fairness.
P. Rules RegardingFurosemide
The Pitts Bill sets forth express policies regarding usage of
Furosemide, presumably within twenty-four hours of a race (see
Race Day Medications above), though the bill does not say so. 8 8
Specifically, during the first two years following the Act becoming
law, Furosemide could be used only under three circumstances:
(1) the horse is 3 years old, or older; (2) the use complies with the
Substances"
Prohibited
and
"Medications
ARCI-011-020
requirements; and (3) administration of this substance occurred
as part of the veterinary care of the animal.89

6 H.R. 3084 § 7(b)(1).
Protocol for Olympic and Paralympic Movement Testing, U.S. ANTI-DOPING
AGENCY 1, 33-37 http://www.usada.org/wp-content/uploads/USADA~protocol.pdf (last
visited Oct. 23, 2016) [https://perma.cc/5KTK-PH951.
8 H.R. 2641 § 4(f).
89 Id.
87
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Most notable of these requirements is that by
incorporating the Principles of Veterinary Medical Ethics into the
bill, only those horses that are demonstrated "bleeders" would be
eligible for Furosemide, as those standards require a diagnosis of
an ailment prior to any treatment.9 0 In contrast, the Barr-Tonko
Bill is tacit on this issue, which is both interesting and
problematic. The timing and circumstances surrounding the use
of Furosemide are key issues in not only Thoroughbred racing but
also Quarter Horse and Standardbred racing as well.91 For the
Barr-Tonko Bill to be successful it will need to address, with
specificity, the issue of Furosemide, which continues to be
contentious. 92 There are meritorious positions on both sides of
this issue and the future of race-day administration of
Furosemide will be a difficult and contested issue relative to
proposed legislation. 93

Q.

Breed RegistrationRequirement

The Pitts Bill contains references to any breed registry
requirement. 94 In contrast, the Barr-Tonko Bill only applies to
Thoroughbreds.9 5 As such, only those Thoroughbred horses that
are registered with The Jockey Club would be subject to the
THADA's jurisdiction. 96
R. Effect on Off-Track Wagers
The Pitts Bill states that, after enactment of the Act, offsite wagers conducted by host racing associations, and/or
accepted by off-track betting systems, are allowed only with
consent of the newly formed federal Anti-Doping Authority.9 7 The

- Id. §§ 2(4), 4(f).
9' See Daniel Ross, Lasix: the drug debate which is bleeding US horse racingdry,
THE
GUARDIAN
(Aug.
31,
2014,
7:00),
https://www.theguardian.com/sport/2014/aug/31/lasix-drug-debate-bleeding-horse-racing
thttps://perma.cc/4CSA-W4MA].
Id.
9 Id.
92

See H.R. 2641, 114th Cong. § 4 (2015).
- H.R. 3084, 114th Cong. § 3(3) (2015).
9 Id. § 3(16).
9 H.R. 2641 § 4(a).
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Barr-Tonko Bill would expressly govern races that are subject to
interstate, off-track wagering.9 8
S. Temporal Scope of the New Laws
The temporal scope of the newly created law is an issue
not addressed by the Pitts Bill. The competing Barr-Tonko Bill
does address these issues. The Barr-Tonko Bill, as proposed,
would be solely prospective in nature.99 As such, if the BarrTonko Bill becomes law, it would address and apply only to those
violations occurring after it becomes effective and enforceable.1 00
All violations that occurred prior to the enactment of the BarrTonko Bill would be controlled by applicable state law and
industry rules.1 01
III. ANALYSIS
Proponents of both the Barr-Tonko Bill and Pitts Bill
support the national or federal regulation of horseracing, and
include long-term industry leaders such as The Jockey Club. 102
The proponents largely base their position and support of the
legislation on the need for uniformity of two things: (1) a uniform
horseracing medication program and (2) uniformity in testing
laboratories.1 0 3 Proponents argue that uniformity would promote
safety and enhance public confidence in the integrity of the
sport.1 04
Opponents include industry leaders such as the
Horsemen's Benevolent and Protective Association and the

98 H.R. 3084 § 4(b).
9 Id. § 6(c).

100 Id.
101 Id.
t02

T.D.
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21,

Bills,
2015),

http://www.thoroughbreddailynews.com/whats-next-for-competing-anti-doping-bills/
[https://perma.cc/C67E-AS7L].
roa See id. See also National Uniform Medication Program, RACING MEDICATION
& TESTING CONSORTIUM, http://rmtenet.com/national-uniform-medication-program/

(last

visited Oct. 14, 2016) [hereinafter RACING MEDICATION] [https://perma.ccDW7F-UATD].
1n See id.; see Thornton, supra note 102.
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Association of Racing Commissioners International. 0 5 The former
operates on behalf of Thoroughbred racehorse owners, trainers,
and backstretch personnel throughout the United States and
Canada.1 06 The latter is the only umbrella organization of the
official governing and rule making bodies for professional horse
racing in North America and parts of the Caribbean. 107 As such, it
sets standards for racing regulation, medication policy, and drug
testing laboratories.1 0 8

Those on the opposing side of this legislation argue three
things. First, generally speaking, there is already uniformity of
horseracing medication programs and laboratories.1 0 9 This is
evidenced by the fact that all thirty-eight states that presently
have racing programs also have a state agency governing racing
and the rules that prohibit a horse from competing with
performance-enhancing medications.1 10 They argue that the lack
of uniformity in medication programs exists in the area of
therapeutic medications."' There is a general consensus as to
those therapeutic medications that are to be allowed with
differences existing in withdrawal times and threshold levels.112
Second, there is already an adequate accreditation process for
laboratories, and all thirty-eight state programs have access to
testing done by accredited labs.11 3 Third, the proposed antidoping bills are a violation of the Tenth Amendment of the U.S.
Constitution.
Opponents argue that any federal attempt or regulation
over states, as proposed by either anti-doping bills, runs afoul of
the Tenth Amendment, which states: "The powers not delegated

105 Thornton, supra note 102.
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Ass'N OF RACING COMM'R INT'L, http://www.arci.com/ (last visited Oct. 14,
2016) [https://perma.cc458M-Q3VRI.
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- See Daniel Ross, Standard issue: drug testing far from uniform in American
horse
racing,
THE
GUARDIAN
(Sept.
16,
2015),
https://www.theguardian.com/sport/2015/sep/16/standard-issue-drug-testing-far-fromuniform-in-american-horse-racing [https://perma.cc/S6R3-5JJZ].
0 Id.
I See id.
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See id.

11

Id.

55

PITTs VS. BARR-TONKO BILLS

2016-2017

to the United States by the Constitution, nor prohibited by it to
the States, are reserved to the States respectively, or to the
people."11 4 I believe there are several troubling issues with both

proposed anti-doping bills. The first is the proposed involvement
of the USADA and its ability to handle the volume of work it
would be required to assume, based on the way both bills are
written. Although the USADA has been largely effective in
testing human athletes, equine athletes, in both size and scope,
present far different challenges than testing a group of Olympic
pole-vaulters.
Let's start with the sheer number of races. There are more
than 96,000 horse races run each year in the United States." 5
The winner of each race is tested, and that testing includes both
urine samples and blood serum samples."- The number of tests
currently performed on equine athletes exceeds 300,000 per
year.11 7 The USADA presently conducts less than 10,000 tests per
year," 8 which equates to less than one-thirtieth of the number of
drug tests that are being performed annually on racehorses. This
raises a serious question as to how the USADA will accommodate
the dramatic increase in numbers while, at the same time,
conducting the necessary research and testing to target the everevolving designer drugs and compounds that are allegedly being
used by industry cheaters. Opponents maintain the USADA will
not do so effectively.
A second issue of concern is how the World Anti-Doping
Code ("WADC") will be implemented, should either of the
proposed anti-doping bills become law. The WADC allows
participants to apply for permission to use certain otherwise

U.S. CONST. amend. X.

Drug Testing By

The Numbers,

HARNESsRACING

(Aug.

14,

2013),

http://www.harnessracing.com/news/drugtestingbythenumbers.html

[https://perma.cc/EZ7F-7RAXJ.
"' Gov. Edmund G. Brown Jr., CHRB Drug Testing and Enforcement, CAL.
BD.
RACING
HORSE
http://www.chrb.ca.gov/miscdoes/drug-testing-enforcement-process.pdf

[https://perma.cc/Q6QM-CFDW1.
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118
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prohibited substances. 119 This application process, filed by or on
behalf of the athlete, seeks a Therapeutic Use Exemption
("TUE").120 The TUE provides the athlete special permission to
use an otherwise prohibited medication or substance. 12 1 A recent
example of a high profile athlete applying for and receiving a
TUE is Olympic Gold Medal Gymnast, Simone Biles, who
received a TUE that allowed her to compete while continuing to
take her ADHD medication.1 22 Significantly, approximately eight
out of ten athletes applying for a TUE are favorably considered. 123
Neither proposed bill contemplates, nor will there be, a TUE for
the equine athlete.1 24
The issue of and desire for uniformity is a key objective of
those on both sides of this issue. Supporters of the Barr-Tonko
Bill and/or the Pitts Bill believe an independent, nongovernmental anti-doping authority charged with implementing a
National Uniform Medication Program ("NUMP") is the solution.
Proponents of those bills point to the fact that despite
development of a NUMP, only eleven states have fully adopted
the same while the remaining states operate under their own
specific rules.1 25 Opponents of the proposed anti-doping bills
argue the existing NUMP, together with a list of permissible
therapeutic medications and recommended withdraw times and
thresholds, is adequate.1 26 Additionally, opponents of the bills

'9 Therapeutic Use Exemptions, WORLD ANTI-DOPING AGENCY 1, 13 (Nov. 20,

2015),
http://www.usada.org/wp-content/uploads/WADA-ISTUE.pdf
[https://perma.cc/2H49-3JYM].
120 Id. at 1.
121

Id.

122

H. G., A doper's dupe?: How athletes can use medical exemptions to beat drug

testers,
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(Sept.

19,

2016),

http://www.economist.com/blogs/gametheory/2016/09/doper-s-dupe [https://perma.cc/66GBMZ5TI.
12 2015 USADA Annual Report, U.S. ANTI-DOPING AGENCY 1, 31 (2015),
http://www.usada.org/wp-content/uploads/2015_annual report.pdf [https://perma.cc/7V48HQK3].
121 H.R. 3084, 114th Cong. (2015). See H.R. 2641, 114th Cong. (2015).
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http://rmtcnet.com/wp-content/uploads/2016/09/NUMP-Policy-Adoption-by-State-handleand-races-September-15-2016.pdf (last visited Oct. 23, 2016) [https://perma.cclE78V-

QJ5YI.
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argue that accredited laboratories are currently performing
testing and that what is really needed is unity among industry
leaders. 127 Unity, argue the opponents, will result in desired
uniformity. 128
IV. CONCLUSION
a middle-ground
is
compromise
The
appropriate
agreement by and between existing state regulators. For
example, multiple states could form a compact agreement that
enhancing
all performance
prohibit
universally
would
medications, yet allow for certain therapeutic medications that
would have defined thresholds and withdraw times. This would
eliminate
confusion
for owners,
trainers,
veterinarians,
regulators, and horsemen that compete in multiple states.
With that said, passage of either proposed anti-doping bill
in its current form is unlikely. Data from the Association of
Racing Commissioners International indicate that approximately
four percent of its members support either bill. 129 The Jockey
Club member support is approximately ten percent. 130 Further,
the government transparency organization, GovTrack, gives the
Barr-Tonko and Pitts Bills a five percent and three percent
chance of getting past committee and a two percent and one
percent chance of being enacted, respectively. 13 1
However, and this is a big however, a nationally televised
tragedy such as Barbaro or Eight Belles in a graded stakes race
could change that figure and shift support to more regulation
overnight. Because of this, compromise, including an exchange of
ideas and the ongoing development of specific regulations should
remain a critical goal of everyone in the horse racing industry.

expresses-concern-over-proposed-horseracing-integrity-act/
UFMK]. 127 Id.
128

[https://perma.cclRDA7-

Id.

Eric Mitchell, 2016: Year of Unification, BLOODHORSE (Dec. 23, 2015, 6:43
PM), http://cs.bloodhorse.com/blogs/wgoh/archive/2015/12/23/2016-year-of-unification.aspx
[https://perma.cc/C346-T35Q].
-n See generally James L. Gagliano, Coalition for Horse Racing Integrity, THE
JOCKEY CLUB, http://www.jockeyclub.com/default.asp?section=RT&year=2015&area=12
(last visited Oct. 23, 2016) (stating that 1200 individuals have signed on to support
WHOA) [https://perma.cc/ZD5Z-RZBE].
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Ultimately, it is up to all those who participate in and benefit
from the sport to increase public confidence, improve
participation, ensure animal safety and welfare, and maintain
integrity
in
the
sport
of
horse
racing.
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BILLS

Table 1. Pitts vs. Barr-Tonko Bills: A Comparison Guide

Name

Applies To

Pitts
The HorseracingIntegrity and
Safety Act of 2015 ("HR 2641")

Thoroughbred,
Quarter Horse,
and Standardbred

Barr-Tonko
The Thoroughbred
HorseracingIntegrityAct of
2015
("HR 3084")
Thoroughbred racing only.

racing.

Primary
Focus

Proposes a ban on providing
medications within twentyfour hours of a race, and a
"three strikes and you're out"
penalty.

Oversight
Authority

An independent Anti-Doping
Authority that would regulate
interstate horseracing at the
federal level.

Veterinary
Ethics

Mandates that all drug
treatments adhere to the
Principles of Veterinary
Medical Ethics of the
American Veterinary Medical
Association ("AVMA") that are
in effect on the date the bill
becomes law. It would take an

Proposes provisions based,
in part, on United States
Anti-Doping Agency
("USADA") Protocol and its
attached World Anti-Doping
Code Articles ("WADCA").
Proposes to use existing
industry "best-practices" to
create a uniform antidoping program along the
lines of the one used in
human sports.
Thoroughbred
Horseracing Anti-Doping
Authority ("THADA")
comprised of owners,
breeders, trainers, vets,
racing associations, and
jockeys.
Does not require adherence
to the standards of
veterinary ethics unless
required by the THADA.
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Race-day
Medication

Pitts
act of Congress to make
changes when the AVMA
modifies its Principles from
time to time.
No medication can be
administered within a 24-hour
window before a race.
Medication administered more
than twenty-four hours before
a race is acceptable, even if it
is still in the horse's
bloodstream during the race.

Vol. 9 No. 1

Barr-Tonko

Tacit on the issue of
whether or not to ban the
administration of
medications on race-day or
go further and ban
medications that may have
an effect on a horse on raceday. This issue is left to the
discretion of the THADA.

Charcter of
New AntiDoing
Authority

Designates the USADA as the
independent anti-doping
organization to regulate
interstate horseracing at the
federal level. Is vague on the

Supplies detailed guidance
about the non-profit
authority to be created by
the THADA.

details.

Duties of the
Anti-Doping
Authority

Leaves it up to the USADA to
develop lists of banned and
allowed substances, methods
and treatments, create
educational, research, and
testing programs, and address

Outlines very specific
details about the duties of
the anti-doping authority.

violations.

Powers of the
Anti-Doping
Authority

Offers no detail regarding the
powers of the USADA AntiDoping Authority.

Sets forth the basic powers
of the THADA. Specifically,
these powers include: (a)
access to the offices, track
facilities, and businesses of
all licensees; (b) the powers
of search and seizure; (c) the
ability to issue and enforce
subpoenas (to compel
persons to be questioned
concerning alleged

2016-2017
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Pitts

Barr-Tonko
violations under oath), and
subpoenas duces tecum
(compelling the production
of documents relevant to
such an investigation by the
authority); as well as, (d)
"other" investigatory
powers.

Doping
Penalties

Adjudication
and
Disciplinary
Procedure

Includes three factors but no
financial penalties, including
no return of the purse. (1) A
"one and done" temporal
exclusion penalty for the
presence of any listed banned
substance in a tested animal;
(2) a "three strikes and you're
out" temporal exclusion
penalty for violations involving
allowed substances that are
found to have been
administered in violation of
the allowed pre-race window,
and; (3) reciprocal federal
suspensions matching any
temporal exclusion penalties
imposed by State Racing
Commissions pursuant to state
law.
Fails to detail any disciplinary
procedures, noting that the
USAoA will establish them if
the bill is enacted. It's likely
the discipline from the
Administrator Order and
Procedures Act will be used.

Imposes
punishment/penalties for 11
areas of violation. The
THADA would be tasked
with creating a uniform set
of rules imposing sanctions
against covered persons for
anti-doping rule violations
and they must include the
imposition of sanctions up
to and including lifetime
bans from horseracing.

Bases its rules largely on
those employed by the
USADA and international
best practices. Sets forth the
main components of
disciplinary actions,
however, the specific
mechanics of the
adjudication and

62

KY. J. EQUINE, AGRI., & NAT. RESOURCES L.

Pitts

Preemption of
State Law and
Reciprocity
Regarding
State Law
Violations
Delegation of
Authority to
State~

Expressly provides that state
laws would not be preempted
by its enactment.

Does not address the issue of
delegation of authority.

Commissions

Barr-Tonko
disciplinary procedures are
left to be established by the
future rules.

Provides for a new regime
regarding anti-doping rules
and regulations that
would/will preempt state
law on the same or similar
subject matter.
States that the THADA may
enter into agreements (i.e.,
contracts) with State Racing
Commissions to implement
the strictures of the Act
within that/those state(s)
specific

Funding

Funding for the new federal
program would derive from
individual agreements
between the USADA and the
racetracks that offer interstate
wagering. Whether there
would be individually
negotiated agreements bearing
some commonality or not, is

Federal
Review

not addressed. The Pitts Bill
does not describe how costs
should be allocated among the
various tracks or how the
USADA should arrive at its
annual horseracing antidoping budgets.
No federal review for spending
or efficacy.

Vol. 9 No. 1

jurisdiction(s).

Initial funding of the
THADA is to be supplied by
loans andlor donations
secured by the TTADA.
Once it is up and running,
the bill requires the THADA
to create a budget each
year, with the first year's
budget being subject to a
supermajority vote of its
board.

In the third year of
operation and every fourth
year thereafter, the

2016-2017
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Pitts

Public Notice
and Comment
Period for
Rules to Be
Promulgated

Requires public and industry
comment with regard to the
permitted/prohibited drugs
lists only.

Rule
Promulgation
Deadline

New rules are to be published
within one year of enactment
of the law.

Barr-Tonko
Comptroller General would
supply congress with a
report evaluating the
THADA's spending and
efficacy.
Requires public comment on
all aspects of its anti-doping
program including, without
limitation, drug lists
(including periodic reviews),
and types of rule violations,
hearings, and sanctions.

The lists of permitted and
prohibited substances and
methods would be published
by January 1, 2017, with
additional enforcement
details.

Testing to Be
Performed By

The bill does not address this
issue.

Testing is to be performed
by independent, THADA-

The new federal Anti-Doping
Authority may suspend a
violator's period of exclusion if
the violator cooperates and
supplies "substantial
assistance" regarding other
violations of the Act's anti
rules, or any state or

pursuant to the procedural
rules to be promulgated
once the Act is enacted.
Provides details related to
the requirement that
federal law will follow the
sanction elimination and
reduction policies found in
the USADA Anti-Doping
Protocol.
tdoping

accredited laboratories,

Reduction in
Penalty for
Cooperation
and Informing

law.
Rules
Regarding
Furosemide

feerlawwilolowthfederal

Sets forth specific policies.
During the first two years
following entry of the Act

Makes no express mention
of Furosemide, leaving the
question of its usability and

becoming law, Furosemide

timing up to the THADA.
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Pitts
could be used only under three
circumstances: (1) the horse is
3 years old, or older; (2) the
use complies with the ARCI011-020 "Medications and
Prohibited Substances"
requirements; and (3)
administration of this
substance occurred as part of
the veterinary care of the

Vol. 9 No. 1

Barr-Tonko

animal.

Breed
Registration
Requirement
Effect on OffTrack Wagers

Temporal
Scope of the
New Laws

Covers Thoroughbreds,
Standardbreds, and Quarter
Horses.
After enactment of the Act, offsite wagers conducted by host
racing associations, and/or
accepted by off-track betting
systems, are allowed only with
consent of the newly formed
federal Anti-Doping Authority.
Not addressed.

Covers only Thoroughbreds.

Vague and without detail.
States only that this federal
law would expressly cover
races that are the subject of
interstate, off-track wagers.

Applies only to those
violations occurring after
the Bill became effective
and enforceable. All
violations that occurred
prior to the enactment of
the Barr-Tonko Bill would
be controlled by applicable
state law and industry
rules.

